TA
Insider buying
Troy A. Ignelzi bought $144K of RAPP stock
Troy A. Ignelzi, Chief Financial Officer of Rapport Therapeutics, Inc. (RAPP), bought 5,500 shares of RAPP stock worth $144K, per an SEC Form 4 filed Oct 21, 2026.
It was an open-market purchase.
The trade was reported on Oct 21, 2026.
RAPP has moved +3.5% since the trade date, from $25.06 to $25.93 (Oct 23, 2026 close).
- Traded
- Oct 21, 2026
- Disclosed
- Oct 21, 2026
- Filing delay
- 0 days
- Price since
- +3.5%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More RAPP insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.